Torque Teno virus, formerly known as transtransfer virus (TTV), is a virus belonging to the Anelloviridae family. First reported in 1997 by Japanese researcher T. Nishizawa, this virus is extremely common in healthy individuals, with infection rates reaching 100% in some countries. About 10% of blood donors in the UK and US carry the virus. Although there are no obvious symptoms of hepatitis, Torque Teno virus often coexists with patients with liver disease, sparking curiosity and discussion about its true impact.
Torque Teno virus is widely distributed around the world and may be transmitted through a variety of routes, such as saliva and sexual contact.
The initial discovery of TTV came from the medical records of a Japanese patient. At that time, researchers used representative difference analysis (RDA) technology to extract the viral gene sequence from the patient's plasma. The earliest gene bank sequence was 500 nucleotides, which was later expanded to about 3700 nucleotides. With in-depth analysis of genome characteristics, TTV was considered to be related to the Circoviridae family, and was eventually renamed Torque Teno virus, which means "slender necklace".
The widespread infection with Torque Teno virus has led to many epidemiological studies showing its distribution in rural and urban populations in Africa, North and South America, Asia, Europe and Oceania. Although a direct link between the virus and specific pathological conditions has not yet been established, studies have shown that there may be some correlation between viral load and the immune status of the host.
The genome of Torque Teno virus consists of a negative-sense circular single-stranded DNA with a length of approximately 3.8kb, and the diameter of the virus particle is approximately 40 nanometers.
Currently, Torque Teno virus is not thought to cause disease in humans. Infected individuals often carry the virus for life, but its potential association with certain diseases still needs further investigation. For example, studies have shown that high viral loads may be associated with immune system diseases such as severe idiopathic myopathies, cancer, and lupus. The virus was detected in 91% of 135 gastroenteritis patients in Brazil, showing the prevalence of the virus in different individuals.
There is still a lack of sufficient understanding of the replication mechanism of Torque Teno virus. Some studies have shown that the double-stranded replication structure observed in Circovirus studies in some animals may also play an important role in TTV replication. Notably, double-stranded TTV DNA in various tissues indicates active replication of the virus at these sites, further weakening the hypothesized association of TTV with liver disease.
Studying Torque Teno virus will not only improve understanding of its biological characteristics, but may also reveal its potential in the assessment of immune function.
Torque Teno virus is undoubtedly an interesting area of research, and although the current evidence is not enough to clearly illustrate a direct relationship between it and liver disease, the impact of this virus may gradually become clearer with further research in the future. With the help of new technologies, we may be able to delve deeper into the secrets of this virus. How does it interact with the human immune system?